Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Coeptis Therapeutics Holdings, Inc. (COEP) had Weighted-Average Shares Outstanding (Diluted) of 4.75M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.24M |
|
$-2.74M |
|
$0.05M |
|
$0.19M |
|
$2.71M |
|
$-2.48M |
|
$-0.42M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.48M |
|
$-2.12M |
|
4.75M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
4.75M |
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$5.99M |
|
$0.01M |
|
$8.19M |
|
$14.18M |
|
$2.71M |
|
$0.15M |
|
$0.56M |
|
$3.26M |
|
$10.92M |
|
$10.51M |
|
$10.92M |
|
5.16M |
|
| Cash Flow Statement Financials | |
$-6.92M |
|
-- |
|
$11.29M |
|
$0.53M |
|
$4.91M |
|
$4.38M |
|
$4.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.21 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
80.98% |
|
-1043.22% |
|
-1043.22% |
|
-- |
|
-1220.84% |
|
-1153.72% |
|
$-6.92M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
2.76 |
|
32.61 |
|
-26.55% |
|
-27.58% |
|
-20.44% |
|
-26.19% |
|
$2.12 |
|
$-1.46 |
|
$-1.46 |
|